 | • レポートコード：TPM-C02120 • 出版社/出版日：Transparency Market Research / 2018年10月30日 • レポート形態：英文、PDF、212ページ • 納品方法：Eメール • 産業分類：Pharmaceutical |
| Single User | ￥857,660 (USD5,795) | ▷ お問い合わせ |
| Multi User | ￥1,301,660 (USD8,795) | ▷ お問い合わせ |
| Global Site License | ￥1,745,660 (USD11,795) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本資料は、薬剤溶出バルーンの世界市場について調べ、薬剤溶出バルーンの世界規模、市場動向、市場環境、製品別（冠動脈薬物溶出バルーン、末梢薬物溶出バルーン）分析、薬剤コーティング技術別（Paccocath、FreePac、TransPax、EnduraCoat）分析、アメリカ市場規模、ヨーロッパ市場規模、アジア市場規模、日本市場規模、中国市場規模、関連企業情報などをまとめた調査レポートです。 ・序文・調査範囲・調査手法 ・エグゼクティブサマリー ・薬剤溶出バルーンの世界市場動向 ・薬剤溶出バルーンの世界市場環境 ・薬剤溶出バルーンの世界市場規模 ・薬剤溶出バルーンの世界市場規模：製品別（冠動脈薬物溶出バルーン、末梢薬物溶出バルーン） ・薬剤溶出バルーンの世界市場規模：薬剤コーティング技術別（Paccocath、FreePac、TransPax、EnduraCoat） ・薬剤溶出バルーンの世界市場：地域別市場規模・分析 ・薬剤溶出バルーンの北米市場規模・予測 ・薬剤溶出バルーンのアメリカ市場規模・予測 ・薬剤溶出バルーンの中南米市場規模・予測 ・薬剤溶出バルーンのヨーロッパ市場規模・予測 ・薬剤溶出バルーンのアジア市場規模・予測 ・薬剤溶出バルーンの日本市場規模・予測 ・薬剤溶出バルーンの中国市場規模・予測 ・薬剤溶出バルーンのインド市場規模・予測 ・薬剤溶出バルーンの中東市場規模・予測 ・薬剤溶出バルーンのアフリカ市場規模・予測 ・競争状況・関連企業情報 |
Drug Eluting Balloon Market – Overview
This report studies the current as well as future prospects of the global drug eluting balloon market. Stakeholders of this report include companies and intermediaries engaged in the manufacturing, commercialization, and provision of e eluting balloons and new players planning to enter the market. The report comprises an elaborate executive summary, along with a market snapshot, providing overall information on various segments considered in the scope of the study. The section also provides information and data analysis of the global drug eluting balloon market in terms of product, drug coating technology, end-user, and region.
The global drug eluting balloon market has been segmented based on product, drug coating technology, end-user, and region. In terms of product, the global market has been classified into coronary drug eluting balloons, peripheral drug eluting balloons, and others. The others segment comprises renal and urology drug eluting balloons. Based on drug coating technology, the market has been divided into Paccocath, FreePac, TransPax, EnduraCoat, and others. The others segment includes the proprietary drug coating technology of BD, Bioshell coating matrix, Biotronik specific coating, and Unicoat. Based on end-user, the global drug eluting balloon market has been segmented into hospitals and ambulatory surgical centers, CATH labs, and others. Hospitals and ambulatory surgical centers is expected to propel the global drug eluting balloon market during the forecast period.
Bottom-up approach has been employed for determining the size of the global drug eluting balloon market, using various market indicators obtained from secondary sources, which include analysis of launched products and mapping of sale of drug eluting balloon of top market players in specific regions. Top-down approach has been used to derive the market size of different product segments, wherein revenue of all publicly listed market players was obtained through secondary sources and analyzed for sales by narrowing down to revenue percentage for product segment through extensive analysis of annual reports, investor presentations, press releases, primary interviews, and others. Data triangulation is based on both secondary research (top-down and bottom- up approaches) and primary research. Moreover, historical year-on-year growth has been taken into consideration while estimating the market size. Market size and forecast, in terms of US$ Mn, for each segment has been provided for the period of 2016 to 2026. The report also provides compound annual growth rate (CAGR) in percentage for each segment for the forecast period, i.e. from 2018 to 2026, considering 2017 as the base year.
The market overview section of the report explores market dynamics, such as, drivers, restraints, opportunities, and key trends that have significant impact on the global drug eluting balloon market and may influence it in the near future. Market attractiveness analysis has been provided to explain the intensity of competition in the market across geographic regions. Competitive scenario existing among the market players has been evaluated through market share analysis in the competitive landscape section of the report. These analyses are likely to help market players take strategic decisions to strengthen their positions and grow their share in the global drug eluting balloon market. The report also comprises price comparison analysis, major mergers & acquisitions, reimbursement scenario by region/global market, overview of clinical trials, patent landscape, and epidemiological overview of cardiovascular diseases, key market trends, value chain analysis, and Porter’s five forces analysis.
In terms of region, the global drug eluting balloon market has been segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. Market size and forecast for each of these regions have been provided for the period from 2016 to 2026, along with their respective CAGR for the forecast period, i.e. from 2018 to 2026, considering 2017 as the base year. The report also provides market size and forecast for major countries in the above mentioned regions. A detailed qualitative analysis of factors responsible for driving and restraining the market and growth opportunities has been provided in the overview section. Competitive landscape section of the report provides analysis of market share of key players, thereby presenting a thorough analysis of the overall competitive scenario in the global drug eluting balloon market.
Major players operating in the global drug eluting balloon market are Medtronic, Becton, Dickinson and Company (BD), Boston Scientific Corporation, Cook Medical, B. Braun Melsungen AG, Koninklijke Philips N.V., Opto Circuits (India) Limited, Terumo Corporation, Surmodics, Inc, and Biotronik.
The global drug eluting balloon market has been segmented as follows:
Global Drug Eluting Balloon Market, by Product Type
Coronary Drug Eluting Balloon
Peripheral Drug Eluting Balloon
Others
Global Drug Eluting Balloon Market, by Drug Coating Technology
Paccocath
FreePac
TransPax
EnduraCoat
Others
Global Drug Eluting Balloon Market, by End-user
Hospitals and Ambulatory Surgery Centers
CATH Labs
Others
Global Drug Eluting Balloon Market, by Region
North America
U.S.
Canada
Europe
U.K.
Germany
France
Italy
Spain
Russia
Rest of Europe
Asia Pacific
China
India
Japan
Australia & New Zealand
Rest of Asia Pacific
Latin America
Brazil
Mexico
Rest of Latin America
Middle East & Africa
GCC Countries
South Africa
Israel
Rest of Middle East & Africa
1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary : Global Drug Eluting Balloon Market
4. Market Overview
4.1. Introduction
4.1.1. Product Type Definition
4.1.2. Industry Evolution / Developments
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global Drug Eluting Balloon Market Analysis and Forecast, 2016–2026
4.4.1. Market Revenue Projections (US$ Mn)
5. Market Outlook
5.1. Reimbursement Scenario
5.2. Cardiovascular Disease Prevalence
5.3. Key Mergers & Acquisitions
5.4. Key Market Trends
6. Global Drug Eluting Balloon Market Analysis and Forecast, by Product Type
6.1. Introduction & Definition
6.2. Key Findings / Developments
6.3. Market Value Forecast, by Product Type, 2016–2026
6.3.1. Coronary Drug Eluting Balloon
6.3.2. Peripheral Drug Eluting Balloon
6.3.3 Others
6.4. Market Attractiveness, by Product Type
7. Global Drug-Eluting Balloon Market Analysis and Forecast, by Drug Coating Technology
7.1. Introduction & Definition
7.2. Key Findings / Developments
7.3. Market Value Forecast, by Drug Coating Technology, 2016–2026
7.3.1. Paccocath
7.3.2. FreePac
7.3.3. TransPax
7.3.4. EnduraCoat
7.3.5. Others
7.4. Market Attractiveness, by Drug Coating Technology
8. Global Drug Eluting Balloon Market Analysis and Forecast, by End-user
8.1. Introduction & Definition
8.2. Key Findings / Developments
8.3. Market Value Forecast, by End-user, 2016–2026
8.3.1. Hospitals & Ambulatory Surgical Centers
8.3.2. Cath Labs
8.3.3. Others
8.4. Market Attractiveness, by End-user
9. Global Drug Eluting Balloon Market Analysis and Forecast, by Region
9.1. Key Findings
9.2. Market Value Forecast, by Region
9.2.1. North America
9.2.2. Europe
9.2.3. Asia Pacific
9.2.4. Latin America
9.2.5. Middle East & Africa
9.3. Market Attractiveness, by Country/Region
10. North America Drug Eluting Balloon Market Analysis and Forecast
10.1. Introduction
10.1.1. Key Findings
10.2. Market Value Forecast, by Product Type, 2016–2026
10.2.1. Coronary Drug Eluting Balloon
10.2.2. Peripheral Drug Eluting Balloon
10.2.3. Others
10.3. Market Value Forecast, by Drug Coating Technology, 2016–2026
10.3.1. Paccocath
10.3.2. FreePac
10.3.3. TransPax
10.3.4. EnduraCoat
10.3.5. Others
10.4. Market Value Forecast, by End-user, 2016–2026
10.4.1. Hospitals & Ambulatory Surgical Centers
10.4.2. Cath Labs
10.4.3. Others
10.5. Market Value Forecast, by Country, 2016–2026
10.5.1. U.S.
10.5.2. Canada
10.6. Market Attractiveness Analysis
10.6.1. By Product Type
10.6.2. By Drug Coating Technology
10.6.3. By End-user
10.6.4. By Country
11. Europe Drug Eluting Balloon Market Analysis and Forecast
11.1.Introduction
11.1.1. Key Findings
11.2.Market Value Forecast, by Product Type, 2016–2026
11.2.1. Coronary Drug Eluting Balloon
11.2.2. Peripheral Drug Eluting Balloon
11.2.3 Others
11.3.Market Value Forecast, by Drug Coating Technology, 2016–2026
11.3.1. Paccocath
11.3.2. FreePac
11.3.3. TransPax
11.3.4. EnduraCoat
11.3.5. Others
11.4.Market Value Forecast, by End-user, 2016–2026
11.4.1. Hospitals & Ambulatory Surgical Centers
11.4.2. Cath Labs
11.4.3. Others
11.5.Market Value Forecast, by Country/Sub-region, 2016–2026
11.5.1. Germany
11.5.2. U.K.
11.5.3. France
11.5.4. Italy
11.5.5. Spain
11.5.6. Rest of Europe
11.6.Market Attractiveness Analysis
11.6.1. By Product Type
11.6.2. By Drug Coating Technology
11.6.3. By End-user
11.6.4. By Country/Sub-region
12. Asia Pacific Drug Eluting Balloon Market Analysis and Forecast
12.1.Introduction
12.1.1. Key Findings
12.2.Market Value Forecast, by Product Type, 2016–2026
12.2.1. Coronary Drug Eluting Balloon
12.2.2. Peripheral Drug Eluting Balloon
12.2.3. Others
12.3.Market Value Forecast, by Drug Coating Technology, 2016–2026
12.3.1. Paccocath
12.3.2. FreePac
12.3.3. TransPax
12.3.4. EnduraCoat
12.3.5. Others
12.4.Market Value Forecast, by End-user, 2016–2026
12.4.1. Hospitals & Ambulatory Surgical Centers
12.4.2. Cath Labs
12.4.3. Others
12.5.Market Value Forecast, by Country/Sub-region, 2016–2026
12.5.1. China
12.5.2. Japan
12.5.3. India
12.5.4. Australia & New Zealand
12.5.5. Rest of Asia Pacific
12.6.Market Attractiveness Analysis
12.6.1. By Product Type
12.6.2. By Drug Coating Technology
12.6.3. By End-user
12.6.4. By Country
13. Latin America Drug Eluting Balloon Market Analysis and Forecast
13.1.Introduction
13.1.1. Key Findings
13.2.Market Value Forecast, by Product Type, 2016–2026
13.2.1. Coronary Drug Eluting Balloon
13.2.2. Peripheral Drug Eluting Balloon
13.2.3 Others
13.3.Market Value Forecast, by Drug Coating Technology, 2016–2026
13.3.1. Paccocath
13.3.2. FreePac
13.3.3. TransPax
13.3.4. EnduraCoat
13.3.5. Others
13.4.Market Value Forecast, by End-user, 2016–2026
13.4.1. Hospitals & Ambulatory Surgical Centers
13.4.2. Cath Labs
13.4.3. Others
13.5.Market Value Forecast, by Country/Sub-region, 2016–2026
13.5.1. Brazil
13.5.2. Mexico
13.5.3. Rest of Latin America
13.6.Market Attractiveness Analysis
13.6.1. By Product Type
13.6.2. By Drug Coating Technology
13.6.3. By End-user
13.6.4. By Country/Sub-region
14. Middle East & Africa Drug-Eluting Balloon Market Analysis and Forecast
14.1.Introduction
14.1.1. Key Findings
14.2.Market Value Forecast, by Product Type, 2016–2026
14.2.1. Coronary Drug Eluting Balloon
14.2.2. Peripheral Drug Eluting Balloon
14.2.3 Others
14.3.Market Value Forecast, by Drug Coating Technology, 2016–2026
14.3.1. Paccocath
14.3.2. FreePac
14.3.3. TransPax
14.3.4. EnduraCoat
14.3.5. Others
14.4.Market Value Forecast, by End-user, 2016–2026
14.4.1. Hospitals & Ambulatory Surgical Centers
14.4.2. Cath Labs
14.4.3. Others
14.5.Market Value Forecast, by Country/Sub-region, 2016–2026
14.5.1. GCC Countries
14.5.2. South Africa
14.5.3. Israel
14.5.4. Rest of Middle East & Africa
14.6.Market Attractiveness Analysis
14.6.1. By Product Type
14.6.2. By Drug Coating Technology
14.6.3. By End-user
14.6.4. By Country/Sub-region
15. Competition Landscape
15.1.Market Player – Competition Matrix (by Tier and Size of companies)
15.2.Market Share Analysis, by Company (2017)
15.3. Competitive Business Strategies
15.4. Company Profiles
15.4.1. Bayer AG
15.4.1.1. Company Overview (HQ, Business Segments, Employee Strength)
15.4.1.2. Product Portfolio
15.4.1.3. SWOT Analysis
15.4.1.4. Strategic Overview
15.4.1.5. Financial Overview
15.4.2. Medtronic
15.4.2.1. Company Overview (HQ, Business Segments, Employee Strength)
15.4.2.2. Product Portfolio
15.4.2.3. SWOT Analysis
15.4.2.4. Strategic Overview
15.4.2.5. Financial Overview
15.4.3. B. Braun Melsungen AG
15.4.3.1. Company Overview (HQ, Business Segments, Employee Strength)
15.4.3.2. Product Portfolio
15.4.3.3. SWOT Analysis
15.4.3.4. Strategic Overview
15.4.3.5. Financial Overview
15.4.4. Cook Medical, Inc.
15.4.4.1. Company Overview (HQ, Business Segments, Employee Strength)
15.4.4.2. Product Portfolio
15.4.4.3. SWOT Analysis
15.4.4.4. Strategic Overview
15.4.4.5. Financial Overview
15.4.5. Boston Scientific Corporation
15.4.5.1. Company Overview (HQ, Business Segments, Employee Strength)
15.4.5.2. Product Portfolio
15.4.5.3. SWOT Analysis
15.4.5.4. Strategic Overview
15.4.5.5. Financial Overview
15.4.6. Becton, Dickinson and Company
15.4.6.1. Company Overview (HQ, Business Segments, Employee Strength)
15.4.6.2. Product Portfolio
15.4.6.3. SWOT Analysis
15.4.6.4. Strategic Overview
15.4.6.5. Financial Overview
15.4.7. EuroCor
15.4.7.1. Company Overview (HQ, Business Segments, Employee Strength)
15.4.7.2. Product Portfolio
15.4.7.3. SWOT Analysis
15.4.7.4. Strategic Overview
15.4.7.5. Financial Overview
15.4.8. Terumo Corporation
15.4.8.1. Company Overview (HQ, Business Segments, Employee Strength)
15.4.8.2. Product Portfolio
15.4.8.3. SWOT Analysis
15.4.8.4. Strategic Overview
15.4.8.5. Financial Overview
15.4.9. Koninklijke Philips N.V
15.4.9.1. Company Overview (HQ, Business Segments, Employee Strength)
15.4.9.2. Product Portfolio
15.4.9.3. SWOT Analysis
15.4.9.4. Strategic Overview
15.4.9.5. Financial Overview
15.4.10. Other Prominent Players
15.4.10.1. Company Overview (HQ, Business Segments, Employee Strength)
15.4.10.2. Product Portfolio
15.4.10.3. SWOT Analysis
15.4.10.4. Strategic Overview
15.4.10.5. Financial Overview
Table 1: Key Mergers and Acquisitions on Drug Eluting Balloon
Table 2: Snapshot of Ongoing Research on Drug Eluting Balloon
Table 3: Recent Patents on Drug Eluting Balloon
Table 4: Global Drug Eluting Balloon Market Value (US$ Mn) Forecast, by Product Type, 2016-2026
Table 5: Global Drug Eluting Balloon Market Value (US$ Mn) Forecast, by Drug Coating Technology, 2016-2026
Table 6: Global Drug Eluting Balloon Market Size (US$ Mn) Forecast, by End-user, 2016-2026
Table 7: Global Drug Eluting Balloon Market Size (US$ Mn) Forecast, by Region, 2016-2026
Table 8: North America Drug Eluting Balloon Market Size (US$ Mn) Forecast, by Country, 2016–2026
Table 9: North America Drug Eluting Balloon Market Size (US$ Mn) Forecast, by Product Type, 2016–2026
Table 10: North America Drug Eluting Balloon Market Size (US$ Mn) Forecast, by Drug Coating Technology, 2016–2026
Table 11: North America Drug Eluting Balloon Market Size (US$ Mn) Forecast, by End-user, 2016–2026
Table 12: Europe Drug Eluting Balloon Market Size (US$ Mn) Forecast, by Country/Sub-region, 2016–2026
Table 13: Europe Drug Eluting Balloon Market Size (US$ Mn) Forecast, by Product Type, 2016–2026
Table 14: Europe Drug Eluting Balloon Market Size (US$ Mn) Forecast, by Drug Coating Technology, 2016–2026
Table 15: Europe Drug Eluting Balloon Market Size (US$ Mn) Forecast, by End-user, 2016–2026
Table 16: Asia Pacific Drug Eluting Balloon Market Size (US$ Mn) Forecast, by Country/Sub-region, 2016-2026
Table 17: Asia Pacific Drug Eluting Balloon Market Size (US$ Mn) Forecast, by Product Type, 2016-2026
Table 18: Asia Pacific Drug Eluting Balloon Market Size (US$ Mn) Forecast, by Drug Coating Technology, 2016-2026
Table 19: Asia Pacific Drug Eluting Balloon Market Size (US$ Mn) Forecast, by End-user, 2016-2026
Table 20: Latin America Drug Eluting Balloon Market Size (US$ Mn) Forecast, by Country/Sub-region, 2016-2026
Table 21: Latin America Drug Eluting Balloon Market Size (US$ Mn) Forecast, by Product Type, 2016-2026
Table 22: Latin America Drug Eluting Balloon Market Size (US$ Mn) Forecast, by Drug Coating Technology, 2016-2026
Table 23: Latin America Drug Eluting Balloon Market Size (US$ Mn) Forecast, by End-user, 2016-2026
Table 24: Middle East & Africa Drug Eluting Balloon Market Size (US$ Mn) Forecast, by Country/Sub-region,
Table 25: Middle East & Africa Drug Eluting Balloon Market Size (US$ Mn) Forecast, by Product Type, 2016–2026
Table 26: Middle East & Africa Drug Eluting Balloon Market Size (US$ Mn) Forecast, by Drug Coating Technology, 2016–2026
Table 27: Middle East & Africa Drug Eluting Balloon Market Size (US$ Mn) Forecast, by End-user, 2016–2026